The IASLC Asia Conference on Lung Cancer (ACLC), October 9-11, 2025 in Ho Chi Minh, Vietnam, will address key regional challenges, including the high prevalence of genetic mutations, environmental risk factors, and disparities in healthcare access. The conference will focus on expanding early detection through low-dose CT and AI, advancing biomarker testing, and fostering multidisciplinary collaboration among medical oncologists, surgeons, radiologists, pulmonologists, radiation oncologists, pathologists, and all healthcare providers involved in the care of patients with thoracic malignancies. Sessions will explore strategies to improve access to targeted therapies, immunotherapy, and innovative surgical and radiotherapy techniques. Additionally, discussions will highlight public health initiatives, tobacco control, and approaches to reduce healthcare disparities. Education, training, and patient advocacy will remain central themes, ensuring a sustainable and patient-centered approach to lung cancer care across Asia.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Pricing
Priced per course
12 free · 2 with a listed price · based on 22 courses listed here
Collected from the provider’s public pages · source
Top 6 courses
-
-
-
2026 WCLC Credit Claim Extended
59.5 Credits
-
-
2026 WCLC Credit Claim Live
59.5 Credits
-
- No reviews yet. Be the first to share yours.
Pricing
| Regular Member | $200 |
| Non-Member - Developing Country | $200 |
Listed by the provider · education.iaslc.org
- Enduring / On-demand
- Credit · Up to 14 credits
- $200 member · $200 standard
-
ReleasedOct 11, 2025
-
Last day to claim creditOct 12, 2026 1 day left
-
American Society of Clinical Oncology When Less Is More: Balancing Cost, Toxicity, and Efficacy for Treatment of Lung Cancer in an Era of Sequencing and Combination Therapies – 2026 ASCO Annual Meeting
-
Answers in CME Inc. (AiCME) New Frontiers in Small Cell Lung Cancer: Getting Ready for the Emergence of B7-H3 Directed ADCs
-
Research to Practice Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Small Cell Lung Cancer | 2026 (Symposium Proceedings)
